ArticleAmerican journal of cancer research2026
Methylation of DPP9 regulates immune surveillance in non-small cell lung cancer by promoting macrophage ferroptosis via WWP2 ubiquitination.
Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is one of the most common malignancies worldwide, with approximately 2.2 million new cases diagnosed annually. About 75% of patients die within five years of diagnosis. Non-small cell lung cancer (NSCLC) is the predominant histological subtype. In the present study, we aimed to comprehensively elucidate the effects of dipeptidyl peptidase 9 (DPP9) in model of NSCLC. DPP9 mRNA expression and protein expression were up-regulation in patients with NSCLC. Then, Sh-DPP9 reduced cancer growth in mice model of NSCLC. N6-methyladenosine (m6A) increased DPP9 RNA stability of macrophage in NSCLC. DPP9 reduced immune surveillance and promoted Macrophage ferroptosis in vitro model. Meanwhile, si-DPP9 increased immune surveillance and reduced Macrophage ferroptosis in vitro model. DPP9 increased reactive oxygen species (ROS) ROS-mitochondrial oxidation and mitochondrial damage in Macrophage of vitro model. DPP9 reduced activating transcription factor 4 (ATF4) protein expression to promote WW domain-containing E3 ubiquitin protein ligase 2 (WWP2) ubiquitination in Macrophage. ATF4 inhibitor or WWP2 inhibitor reduced the effects of si-DPP9 in ferroptosis of macrophage in model of NSCLC. In conclusion, DPP9 up-regulation promotes WWP2 ubiquitination, thereby inhibiting the WWP2/ATF4 signaling pathway and enhancing macrophage ferroptosis, which leads to reduced immune surveillance and promotes tumor progression in NSCLC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.